idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instanz:
Teilen: 
01.08.2025 16:01

Depression in Diabetes: Possible Therapeutic Success Through Biomarkers

Susan Jörges Presse- und Öffentlichkeitsarbeit
Deutsches Diabetes-Zentrum

    People with diabetes suffer from depression more frequently than average. Researchers from the German Diabetes Center (DDZ), the Research Institute of the Diabetes Academy Mergentheim (Forschungsinstitut an der Diabetes Akademie Mergentheim, FIDAM) and the German Center for Diabetes Research (DZD) were able to show in a large-scale analysis that biomarkers for chronic inflammation levels influence the therapeutic success of depressive symptoms – however, with considerable differences in type 1 and type 2 diabetes. The findings could help to customize the treatment of depression in people with diabetes in the future.

    People with diabetes have about twice the risk of depression as the general population. The chronic metabolic disease is stressful and often associated with anxiety, excessive demands or negative feelings of illness. Depression can impair the independent treatment of diabetes, increase the risk of complications and have a negative impact on life expectancy. This makes early diagnosis and effective treatment of depressive symptoms – whether with medication or behavioral therapy – all the more important. However, not all people with diabetes respond equally well to treatment.

    Inflammatory Markers and the Course of Depression were Examined over a Year
    Inflammatory processes could play a key role, as chronic inflammatory reactions in the body are now considered to be a common biological background mechanism for both diabetes and depression. Previous studies have shown: A change in inflammatory markers in the blood can be accompanied by an improvement or worsening of a wide range of depressive symptoms. “Identifying factors associated with therapeutic success in depression is important in order to select the right therapies for people with diabetes,” explains Prof. Christian Herder, first author of the study and Head of the Inflammation working group at the DDZ.

    While previous studies often focused on individual inflammatory markers, this analysis, funded by the German Research Foundation (DFG), used a broad panel of markers in the blood and differentiated between various symptoms of depression. The analysis is based on data from 521 people with type 1 or type 2 diabetes from three different intervention studies at the FIDAM, which investigated the effect of behavioral therapy on people with type 1 and type 2 diabetes and symptoms of depression. Using a questionnaire to record depressive symptoms (Center for Epidemiologic Studies Depression Scale/CES-D) and measuring 76 inflammatory markers in the blood, the research team investigated whether there was a correlation between inflammation levels and changes in the severity of depression within a year.

    Contrasting Effects Depending on the Type of Diabetes
    The results show a surprising pattern: In people with type 2 diabetes and higher inflammatory markers, behavioral therapy significantly improved depressive symptoms – especially cognitive-affective complaints and anhedonia (joylessness). In people with type 1 diabetes and higher inflammation levels, behavioral therapy only achieved a smaller improvement – especially in somatic symptoms such as fatigue, sleep disorders or loss of appetite.

    Why the correlations between inflammatory markers and depressive symptoms differ so significantly in type 1 and type 2 diabetes has not yet been conclusively clarified. It is possible that the different forms of immune activation play a role, i.e., autoimmune processes in type 1 diabetes and metabolic inflammation in type 2 diabetes. “Further studies are needed to better understand the underlying mechanisms and the role of psychotherapeutic and anti-inflammatory treatment approaches,” emphasizes Prof. Michael Roden, Scientific Director and Spokesman of the DDZ Board and Director of the Department of Endocrinology and Diabetology at Düsseldorf University Hospital.

    Significant for the Future: Precision Medicine for Psyche and Metabolism

    The findings could influence future therapy selection: “People with type 2 diabetes and high inflammation levels possibly respond particularly well to a change in depressive cognitions through cognitive behavioral therapy. People with type 1 diabetes and high inflammation levels, on the other hand, could benefit more from anti-inflammatory drug therapies,” explains Prof. Norbert Hermanns from the FIDAM.


    Wissenschaftliche Ansprechpartner:

    Prof. Dr. Christian Herder
    Head of the Inflammation working group
    Institute for Clinical Diabetology
    German Diabetes Center (DDZ)


    Originalpublikation:

    Titel: Biomarkers of inflammation and improvement in depressive symptoms in type 1 and type 2 diabetes: differential associations with depressive symptom clusters
    Autoren: Herder, C., Zhu, A., Schmitt, A. et al.
    Doi: https://doi.org/10.1007/s00125-025-06472-w


    Bilder

    Merkmale dieser Pressemitteilung:
    Journalisten, Wissenschaftler
    Ernährung / Gesundheit / Pflege, Medizin
    überregional
    Forschungs- / Wissenstransfer, Forschungsergebnisse
    Englisch


     

    Hilfe

    Die Suche / Erweiterte Suche im idw-Archiv
    Verknüpfungen

    Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.

    Klammern

    Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).

    Wortgruppen

    Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.

    Auswahlkriterien

    Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).

    Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).